Schiavi & Co’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$836K Buy
3,293
+48
+1% +$11.2K 0.22% 18
2026
Q1
$793K Sell
3,245
-78
-2% -$18.2K 0.24% 18
2025
Q4
$688K Buy
3,323
+90
+3% +$17.8K 0.22% 19
2025
Q3
$599K Buy
3,233
+222
+7% +$38K 0.2% 18
2025
Q2
$460K Hold
3,011
0.16% 18
2025
Q1
$499K Sell
3,011
-125
-4% -$19.6K 0.18% 16
2024
Q4
$454K Sell
3,136
-2
-0.1% -$310 0.18% 15
2024
Q3
$509K Buy
3,138
+2
+0.1% +$319 0.18% 16
2024
Q2
$458K Buy
3,136
+320
+11% +$47.6K 0.18% 16
2024
Q1
$445K Buy
2,816
+5
+0.2% +$796 0.18% 16
2023
Q4
$441K Sell
2,811
-200
-7% -$30.7K 0.18% 18
2023
Q3
$469K Buy
3,011
+200
+7% +$33K 0.2% 15
2023
Q2
$465K Sell
2,811
-160
-5% -$25.8K 0.19% 15
2023
Q1
$461K Hold
2,971
0.2% 13
2022
Q4
$525K Buy
+2,971
New +$513K 0.33% 12

Other funds holding JNJ

Schiavi & Co's JNJ Position: Q2 2026 in Review

Schiavi & Co increased its Johnson & Johnson (JNJ) stake by 1.5% in Q2 2026, buying an estimated $11.2K and bringing the position to 3,293 shares worth $836K. The position accounts for 0.22% of the portfolio, ranked #18.

Schiavi & Co first reported a position in JNJ in Q4 2022 and has held it in 15 quarters since. 4,672 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Schiavi & Co held 3,293 shares of Johnson & Johnson worth $836K as of Q2 2026.
  • Schiavi & Co bought 48 Johnson & Johnson shares in Q2 2026, an estimated $11.2K.
  • Johnson & Johnson made up 0.22% of Schiavi & Co's portfolio in Q2 2026, its #18 holding.
  • Schiavi & Co first reported a position in Johnson & Johnson in Q4 2022 and has held it in 15 quarters since.
  • 4,672 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Schiavi & Co's 13F filing for Q2 2026, filed 10 Aug 2026.